Clinical Trials Logo

Clinical Trial Summary

This study will enroll children between the ages of 4 and 6 years of age who exhibit significant difficulty developing language skills without any other handicapping conditions. Children will receive standardized language, hearing, and cognitive testing to confirm a diagnosis of developmental language disorder. Children will be enrolled in a half-day summer camp program for six weeks during which they will receive treatment designed to improve their language skills. Children will be seen again approximately six weeks after the end of treatment to determine how much learning they have retained.


Clinical Trial Description

Children between 4 years, 0 months and 6 years 11 months are eligible. A diagnosis of developmental language disorders will be confirmed as normal nonverbal cognitive function, passing a pure-tone audiometric screening, and a test score consistent with developmental language disorder on a standardized language test, and parent report of no other diagnosed handicapping condition. Speech skills and vocabulary skills will be described via standardized testing. Children enrolled in treatment are seen for up to 28 consecutive weekdays. The study starts with three days of baseline assessment of morpheme use for potential treatment targets. Two are selected for study, with one treated and one tracked over the course of treatment. Treatment is embedded in child-friendly activities like games, book reading, and craft activities. Children are prompted to use the treated morpheme in conversation. Immediately following this attempt, the treating clinician repeats the child's utterance, correcting any ungrammatical forms. Half of the children will also receive explanations of what the key words in sentences mean (e.g., to twirl means to turn around fast). Generalization to untreated contexts is assessed 2-3 times weekly. Retention of learning is measured about six weeks after the end of treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06250101
Study type Interventional
Source University of Arizona
Contact Rebecca Vance, MS
Phone 520-626-9332
Email rbvance@arizona.edu
Status Recruiting
Phase N/A
Start date June 17, 2024
Completion date January 30, 2026

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06062147 - Impact of Teacher Training and the Introduction of Early Adjustments on the Developmental Trajectory of Children at Risk of SLLD in Pre-school. N/A
Completed NCT05242575 - The Influence of Immersive Virtual Field Trips on Academic Vocabulary N/A
Enrolling by invitation NCT03838016 - Preventing Speech and Language Disorders in Children With Classic Galactosemia N/A
Active, not recruiting NCT05900180 - Pediatric Speech Therapy Session Frequency and Speech Outcomes N/A
Recruiting NCT05133479 - Let's Know!2: Language-focused Intervention for Children at Risk of Comprehension Difficulties N/A
Completed NCT05487521 - EEG Changes in Pediatrics With Language Dysfunction Evaluation of Sleep EEG Changes in Paediatric Patients With Language Dysfunction: A Follow up Study. EEG Changes in Pediatrics With Language Dysfunction Phase 3